Triple Negative Breast Cancer, "I Won't Back Down!": 2019

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Wednesday, August 14, 2019

Toledo Jeep Fest Parade 2019

August 2019, over 1200 jeeps rolled through downtown Toledo, Ohio for their annual Jeep Fest Weekend.

Me watching Jeep Parade

Love my Muddy Mud hen!

Miracles are Pink

Winged Warrior

Pink!

Thursday, August 1, 2019

Young Researchers in Triple Negative Breast Cancer 2019

It's always an honor to go to University of Toledo's Pharmaceutical Science research lab and see first hand what they are working on and the progression of their studies. On July 3, 2019, Dr. Angelique treated me lunch on campus the day before she was about to leave UT for Boston where she will continue her career in pharmaceutical research and wishes to continue her research in Triple Negative Breast Cancer. Saloni of UT will continue researching drug resistance in Triple Negative Breast Cancer in Dr. Amit Tiwari's lab.

Melissa and Dr. Angelique
in her research office

Triple Negative Breast Cancer cells
under the microscope

Saloni viewing results of her study on
Triple Negative Breast Cancer cells

Untreated Triple Negative Breast Cancer Cells

Triple Negative Breast Cancer cells
after being treated with an experimental drug,
destroying the cancer cells.

Friday, July 5, 2019

National Cancer Survivors Day 2019

The Victory gals celebrating life at our annual National Cancer Survivors Day Picnic, June 2019.

Sunday, June 23, 2019

YSC Conference Orlando 2018

Warm weather, palm trees,
and cool cars!

Celebrating 20 years of young survival coalition

YSC CEO, Jennifer Merschdorf

#SquirrelPack4Life YSC reunion

Melissa and Dusty

Tammy, Melissa and Dusty

Until we see you again, Dusty

Tammie and TNBC sisters, Angie Martin, Melissa,
Alex and Jeanna

TNBC sisters Melissa and Karen Koon

Breast Cancer survivors
Tammie and Melissa
#KissThis4MBC

Breast Cancer can
#KissThis4MBC!

#KissThis4MBC campaign

Kick Ass Survivor Melissa
advertising for Healing Heels
https://www.healing-heels.com

Kick Ass (in heels)

A Story Half Told
Remembering Jill Cohen
https://www.storyhalftold.com/meet-jill-cohen

TNBC sisters Melissa, Jeanna, Sara and Lisa
advertising for Triple Negative Breast Cancer
Foundation and promoting #TNBCDay
https://www.tnbcfoundation.org

TNBC sisters with Roxanne on right

TNBC sisters Melissa and Laura D'Alessandro

TNBC sisters Melissa and Joanne Hayashi
"3 negative"

TNBC sisters Melissa and
Alison Mcquillan

TNBC sisters forever!
Angela Martin and Melissa

TNBC Sisters Angie, Melissa
and Laura

TNBC sisters Melissa and
Laura Shepard

Breast Cancer survivors
Melissa and Carol Capelan

Love this group of YSC survivor sisters!

Lookie here:
HOPE in Triple Negative Breast Cancer

Immunomedics pipeline,
Hope in Triple Negative Breast Cancer

Preliminary data shows clinical benefit in patients
with mTNBC with Sacituzumab goviitecan
targeting Trop-2, an epithelial antigen expressed
on many solid tumors